Drug Shortage Report for CASPOFUNGIN FOR INJECTION

Last updated on 2020-09-29 History
Report ID 121039
Drug Identification Number 02486997
Brand name CASPOFUNGIN FOR INJECTION
Common or Proper name Caspofungin for Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CASPOFUNGIN
Strength(s) 70MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 70 mg, 10 mL Vial
ATC code J02AX
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-07-23
Actual start date 2020-07-23
Estimated end date Unknown
Actual end date 2020-09-28
Shortage status Resolved
Updated date 2020-09-29
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that our Caspofungin for Injection, 70 mg Vial, 10 mL will be available at all distribution centres by the week of September 28, 2020 *Please note that the availability date may vary by region, please check with your local distribution centre for availability.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-09-29 English Compare
v5 2020-09-25 French Compare
v4 2020-09-25 French Compare
v3 2020-09-25 English Compare
v2 2020-07-24 French Compare
v1 2020-07-24 English Compare